
Rationalist-adjacent musings on psychiatry
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 45 | Founded | 3 years ago | Last Issue | 7 days ago |
| Active | |||||

This is the first in a series of essays on two major concerns I have with the growing use of transcranial magnetic stimulation (TMS) for depression. The first concern is with TMS research. The second concern is the marketing of TMS. I think...
Unless you live under a rock, the consensus in psychiatry is that benzodiazepines are harmful in PTSD and should be avoided at all costs. Beyond the known risks of benzodiazepines, we are told that they are ineffective for core PTSD symptom...
Work in psychiatry for ~~long enough~~ any amount of time, really, and you will see patients with schizophrenia on some pretty heavy antipsychotic regimens. Here are a few recent med lists that I’ve seen:
Patient A:
Photo via Psychology Pictures (from an experiment in which Skinner taught pigeons to play ping pong)
In 1948, the behavioralist B.F. Skinner published “‘Superstition’ in the Pigeon.”1 Skinner devised a contraption where he took starving pi...
I’ve been preparing lectures on the treatment and bipolar disorder, but I keep running into the same question: what is the point of bipolar II disorder?
I’m not arguing about the validity of the diagnosis, whether it’s underdiagnosed or ov...
Subscribers, engagement, traffic and sponsorship for Polypharmacy.
| Subscribers | Engagement | 77 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #247 |
The writers behind this newsletter.
Psychiatrist, independently minded to a troublesome degree. Occasionally produces original thoughts worth sharing.
An academic psychiatrist trying to improve the quality of evidence in psychiatry. I’m pro humility and against hype and bad science. All views my own. “A cynic is a man who knows the price of everything, and the value of nothing.”
You can find recent issues that have been published by Polypharmacy on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Polypharmacy, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Polypharmacy as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Polypharmacy using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Polypharmacy. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.